2013
DOI: 10.1016/j.yrtph.2013.08.002
|View full text |Cite
|
Sign up to set email alerts
|

Good relationship between saliva cotinine kinetics and plasma cotinine kinetics after smoking one cigarette

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
7
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 17 publications
1
7
0
Order By: Relevance
“…This design choice was intended to explore the use of noninvasive and potentially more sensitive measure of nicotine exposure. To the authors’ knowledge, saliva nicotine has been used in only three published acute exposure studies each involving cigarette smoking (Corrigall et al, 2001; Schramm et al, 1992; Yuki et al, 2013) and an examination of the relationship between saliva and plasma nicotine among nicotine patch users (Rose et al, 1993). This prior work supports the idea saliva nicotine increases following tobacco smoke exposure (Corrigall et al, 2001; Schramm et al, 1992; Yuki et al, 2013), and plasma and saliva nicotine concentrations may be correlated highly ( r = 0.82; Rose et al, 1993).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This design choice was intended to explore the use of noninvasive and potentially more sensitive measure of nicotine exposure. To the authors’ knowledge, saliva nicotine has been used in only three published acute exposure studies each involving cigarette smoking (Corrigall et al, 2001; Schramm et al, 1992; Yuki et al, 2013) and an examination of the relationship between saliva and plasma nicotine among nicotine patch users (Rose et al, 1993). This prior work supports the idea saliva nicotine increases following tobacco smoke exposure (Corrigall et al, 2001; Schramm et al, 1992; Yuki et al, 2013), and plasma and saliva nicotine concentrations may be correlated highly ( r = 0.82; Rose et al, 1993).…”
Section: Discussionmentioning
confidence: 99%
“…To the authors’ knowledge, saliva nicotine has been used in only three published acute exposure studies each involving cigarette smoking (Corrigall et al, 2001; Schramm et al, 1992; Yuki et al, 2013) and an examination of the relationship between saliva and plasma nicotine among nicotine patch users (Rose et al, 1993). This prior work supports the idea saliva nicotine increases following tobacco smoke exposure (Corrigall et al, 2001; Schramm et al, 1992; Yuki et al, 2013), and plasma and saliva nicotine concentrations may be correlated highly ( r = 0.82; Rose et al, 1993). Mean saliva nicotine concentrations observed here (between 190.4 and 952.5 ng/ml) were comparable to those measured in a prior acute settings involving cigarette smokers (Schramm et al, 1992; Yuki et al, 2013).…”
Section: Discussionmentioning
confidence: 99%
“…Thus, there is a need for noninvasive biofluids that are ethically appropriate, cost-efficient, and toxicologically rele-vant [20][21][22]. Studies have demonstrated that the pharmacokinetics in saliva are well correlated with that in plasma [23]. Due to advantages such as noninvasiveness and easy sample collection, saliva is an important body fluid suited to study the pharmacokinetics in humans.…”
Section: Abbreviationsmentioning
confidence: 99%
“…In addition, saliva is a suitable surrogate diagnostic tool for other body fluids as saliva testing is cost-effective, simple and non-invasive [19]. In individuals, salivary cotinine concentrations have been shown to be approximately the same as plasma concentrations [20]. Until now, only few studies aimed to focus on the determinants of SHS exposure, although this information is needed for adequate public health policies to protect non-smokers.…”
Section: Introductionmentioning
confidence: 99%